Nothing Special   »   [go: up one dir, main page]

MX357704B - Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide. - Google Patents

Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.

Info

Publication number
MX357704B
MX357704B MX2014014579A MX2014014579A MX357704B MX 357704 B MX357704 B MX 357704B MX 2014014579 A MX2014014579 A MX 2014014579A MX 2014014579 A MX2014014579 A MX 2014014579A MX 357704 B MX357704 B MX 357704B
Authority
MX
Mexico
Prior art keywords
retinoid
emulsion
topical pharmaceutical
compositions containing
pharmaceutical compositions
Prior art date
Application number
MX2014014579A
Other languages
English (en)
Other versions
MX2014014579A (es
Inventor
Duprat Agnès
Mallard Claire
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of MX2014014579A publication Critical patent/MX2014014579A/es
Publication of MX357704B publication Critical patent/MX357704B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/402—1-aryl substituted, e.g. piretanide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a composiciones farmacéuticas tópicas de tipo emulsión Ag/Ac que contienen un retinoide. La invención se refiere a una composición farmacéutica tópica que comprende, por medio de un ingrediente farmacéutico activo, un retinoide en una composición fisiológicamente estable. La invención también se refiere al método de preparación de la misma y al uso de la misma en dermatología.
MX2014014579A 2012-06-01 2013-05-30 Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide. MX357704B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261654694P 2012-06-01 2012-06-01
FR1255091A FR2991175B1 (fr) 2012-06-01 2012-06-01 Compositions pharmaceutiques topiques de type emulsion h/e contenant un retinoide
PCT/EP2013/061199 WO2013178758A1 (fr) 2012-06-01 2013-05-30 Compositions pharmaceutiques topiques de type émulsion h/e contenant un rétinoïde

Publications (2)

Publication Number Publication Date
MX2014014579A MX2014014579A (es) 2015-03-03
MX357704B true MX357704B (es) 2018-07-20

Family

ID=46826691

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014014579A MX357704B (es) 2012-06-01 2013-05-30 Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.

Country Status (12)

Country Link
US (1) US9855244B2 (es)
EP (1) EP2874619B1 (es)
JP (1) JP2015518033A (es)
KR (1) KR102118226B1 (es)
CN (1) CN104507470B (es)
AU (1) AU2013269581B2 (es)
BR (1) BR112014029874B1 (es)
CA (1) CA2875417A1 (es)
FR (1) FR2991175B1 (es)
MX (1) MX357704B (es)
RU (1) RU2655305C2 (es)
WO (1) WO2013178758A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160235796A1 (en) * 2015-02-13 2016-08-18 Peter Kennedy Topical vasodilator composition
US10478466B1 (en) 2015-02-13 2019-11-19 Peter Kennedy Topical vasodilator composition
US10933018B2 (en) * 2015-10-30 2021-03-02 Timber Pharmaceuticals Llc Isotretinoin formulations and uses and methods thereof
WO2021104515A1 (zh) * 2019-11-29 2021-06-03 迪斯凯威（深圳）新药发展有限公司 一种取代的间三联苯类化合物及其药物组合物和用途
CN118121532A (zh) * 2022-12-02 2024-06-04 南京迈诺威医药科技有限公司 一种含有曲法罗汀的药物组合物及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0706370B2 (en) * 1993-07-01 2005-01-26 Yamanouchi Europe B.V. Use of non-ionic surfactants in stable topical retinoid compositions
FR2709666B1 (fr) * 1993-09-07 1995-10-13 Oreal Composition cosmétique ou dermatologique constituée d'une émulsion huile dans eau à base de globules huileux pourvus d'un enrobage cristal liquide lamellaire.
FR2742677B1 (fr) * 1995-12-21 1998-01-16 Oreal Nanoparticules enrobees d'une phase lamellaire a base de tensioactif silicone et compositions les contenant
US5972355A (en) * 1997-09-30 1999-10-26 E-L Management Corp. Stable compositions containing biologically active components
KR100452972B1 (ko) * 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
US20040213754A1 (en) * 2000-10-02 2004-10-28 Cole Curtis A. Method for cleansing sensitive skin using an alkanolamine
US6881414B2 (en) * 2000-11-22 2005-04-19 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Mild cosmetic composition with stabilized retinoids
SI1485080T1 (sl) * 2002-03-12 2009-10-31 Galderma Res & Dev Uporaba adapalena za zdravljenje dermatoloških motenj
KR20070091613A (ko) * 2004-11-08 2007-09-11 그렌마크 파머수티칼스 엘티디. 항여드름 화합물 및 항생제 화합물을 함유하는 국소적 제약조성물
FR2880020B1 (fr) * 2004-12-23 2007-02-16 Galderma Res & Dev NOUVEAUX LIGANDS MODULATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE
CA2590246C (en) * 2004-12-23 2015-07-14 Galderma Research & Development Novel ligands that modulate rar receptors, and use thereof in human medicine and in cosmetics
WO2007039057A1 (en) * 2005-09-23 2007-04-12 Dsm Ip Assets B.V. Cosmetic compositions comprising hydroxyfatty acids
FR2910321B1 (fr) * 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
FR2910320B1 (fr) * 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2915682B1 (fr) * 2007-05-04 2009-07-03 Galderma Res & Dev Compositions depigmentantes dermatologiques et cosmetiques, leurs procedes de preparation, et leurs utilisations
RU2363461C2 (ru) * 2007-10-03 2009-08-10 Закрытое акционерное общество "Биологические исследования и системы" Фармацевтический препарат для наружного и местного применения на основе сигетина
AU2009331482B2 (en) * 2008-12-22 2014-12-11 Johnson & Johnson Consumer Holdings France A composition comprising a retinoid and method of treating skin conditions
CA2745457A1 (fr) * 2008-12-23 2010-07-01 Galderma S.A. Composition pharmaceutique topique comprenant un principe actif sensible a l'eau

Also Published As

Publication number Publication date
RU2014152992A (ru) 2016-07-27
EP2874619A1 (fr) 2015-05-27
WO2013178758A1 (fr) 2013-12-05
BR112014029874B1 (pt) 2022-01-18
CN104507470A (zh) 2015-04-08
JP2015518033A (ja) 2015-06-25
BR112014029874A8 (pt) 2021-08-24
KR102118226B1 (ko) 2020-06-02
US9855244B2 (en) 2018-01-02
AU2013269581A1 (en) 2014-12-18
US20150148400A1 (en) 2015-05-28
BR112014029874A2 (pt) 2017-06-27
CN104507470B (zh) 2018-06-26
MX2014014579A (es) 2015-03-03
AU2013269581B2 (en) 2018-03-01
CA2875417A1 (fr) 2013-12-05
EP2874619B1 (fr) 2023-01-04
FR2991175A1 (fr) 2013-12-06
RU2655305C2 (ru) 2018-05-24
KR20150016984A (ko) 2015-02-13
FR2991175B1 (fr) 2014-12-19

Similar Documents

Publication Publication Date Title
AU2014359194A1 (en) Lipid microcapsules preferably comprising a retinoid, and composition containing same, method for the production thereof, and use thereof in dermatology
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2015008628A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
WO2012143576A3 (en) Compounds for preventing, reducing and/or alleviating itchy skin condition(s)
MX338515B (es) Derivados de tetrahidroquinolina utiles como inhibidores de bromodominio.
MX351584B (es) Formulacion farmaceutica acuosa de tapentadol para administracion oral.
PH12015501096A1 (en) Composition for immediate and extended release
MX348823B (es) Formulaciones estables de linaclotida.
MY168212A (en) A new therapeutical composition containing apomorphine as active ingredient
TN2012000488A1 (en) Pharmaceutical compositions comprising hydromorphone and naloxone
WO2015056094A3 (en) Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent
WO2014203275A3 (en) An improved process for the preparation of apixaban and intermediates thereof
MX2016001422A (es) Composicion farmaceutica de fingolimod.
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
MX363530B (es) Compuesto de benzoxaborol tricíclico, método de preparación y uso del mismo.
IN2014DN01619A (es)
MX357704B (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
MX2014014517A (es) Composiciones topicas bajo la forma de un gel que contiene un retinoide particular solubilizado.
EP3068436A4 (en) Topical pharmaceutical, cosmetic and disinfectant compositions comprising phosphatidylcholine
WO2015001163A3 (es) Nanopartículas lipídicas para la cicatrización de heridas
EP2871187A4 (en) NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT
WO2012093973A3 (en) Compositions in the form of tablets comprising acarbose
WO2014166836A8 (en) Growth hormone compound formulation
MX2015004314A (es) Formulacion de aroma y fragancia (iii).
MX345263B (es) Formulación de pexiganan estable.

Legal Events

Date Code Title Description
FG Grant or registration